Research on the link between expedited review and drug reevaluation from the perspective of innovation incentive based on the European Union's experience

YAN Jian-zhou; ZHANG Li-yang; LEI Lu-qian; SHAO Rong

doi:10.3969/j.issn.1003-3734.2019.24.001

Home>Articles>Research on the link between expedited review and drug reevaluation from the perspective of innovation incentive based on the European Union's experience

DOI: 10.3969/j.issn.1003-3734.2019.24.001

Research on the link between expedited review and drug reevaluation from the perspective of innovation incentive based on the European Union's experience

YAN Jian-zhou

ZHANG Li-yang

LEI Lu-qian

SHAO Rong

Machine-generated Keywords：

Publication Date：2019-12-31

Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)

Pages：5( 2921-2925 )

Chinese Journal of New Drugs

PKUISTIC

ISSN：1003-3734

Year, Vol.(Issue)：2019,28(24)